NCT02530515 2019-10-29
Ex Vivo-activated Autologous Lymph Node Lymphocytes in Treating Patients With Chronic Lymphocytic Leukemia
M.D. Anderson Cancer Center
Phase 2 Completed
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Cellerant Therapeutics
Amgen